Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-07 Sale | 2024-03-11 6:20 pm | Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D | 4,377 | $90.69 | $396,950 | 72,703 (Direct) | View |
| 2023-10-04 Sale | 2023-10-05 10:47 am | Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D | 3,769 | $48.06 | $181,138 | 62,080 (Direct) | View |
| 2023-03-06 Sale | 2023-03-08 9:34 pm | Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D | 1,948 | $45.68 | $88,977 | 65,849 (Direct) | View |
| 2022-10-04 Sale | 2022-10-05 6:54 pm | Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D | 3,477 | $67.3 | $234,002 | 52,797 (Direct) | View |
| 2022-03-07 Sale | 2022-03-08 4:06 pm | Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D | 1,047 | $56.19 | $58,831 | 56,274 (Direct) | View |
| 2021-10-05 Sale | 2021-10-07 4:26 pm | Blueprint Medicines Corp | BPMC | Namouni Fouad President, R & D | 3,241 | $98.18 | $318,201 | 42,321 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-06 4:21 pm | N/A 2034-03-01 | Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D | 45,000 | $0 | 107,080 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:09 pm | N/A 2033-03-01 | Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D | 45,000 | $0 | 97,797 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 7:59 pm | N/A 2032-03-01 | Blueprint Medicines Corp | BPMC | Namouni Fouad PRESIDENT, R & D | 45,000 | $0 | 87,321 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-01 6:58 pm | N/A 2031-06-30 | Aprea Therapeutics Inc. | APRE | Namouni Fouad Director | 27,360 | $0 | 27,360 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:15 pm | N/A 2031-03-01 | Blueprint Medicines Corp | BPMC | Namouni Fouad President, R & D | 39,187 | $0 | 71,687 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-05 4:16 pm | N/A 2030-10-01 | Blueprint Medicines Corp | BPMC | Namouni Fouad President, R & D | 97,500 | $0 | 97,500 (Direct) | View |
| 2020-06-26 Option Award | 2020-06-29 6:05 pm | N/A 2030-06-26 | Aprea Therapeutics Inc. | APRE | Namouni Fouad Director | 7,000 | $0 | 7,000 (Direct) | View |